As companies face a range of new threats, many are re-evaluating their relationships with third parties to reduce risk and maintain supply chain continuity.
Genpact's enterprise risk and compliance lead, Subhashis Nath, discusses the critical business risks emerging from COVID-19 and their impact in this webinar with Compliance Week. Joining him in the discussion are:
- Joseph Olem, ABAC Program Director, Compliance, Alexion Pharmaceuticals, Inc.
- Jennifer Saperstein, Vice Chair, Anti-Corruption Group, Covington & Burling LLP
- Sharon Zealey, CEO, NextGen Compliance LLC
- Anu Priy Vij, Regulatory Compliance Leader, Genpact
Watch the webinar to hear this panel of experts share best practices for building a robust third-party due-diligence framework, including how to best use digital technologies.